Biopharmaceutical Dealmakers’ Intentions in 2017: Influences and Hot Spots Endpoints News
Each year for the last nine years, inVentiv Health Consulting has surveyed pharmaceutical and biotech dealmakers to assess their intentions for the next 12 …
Biopharmaceutical Dealmakers’ Intentions in 2017: Influences and Hot Spots Endpoints News
Each year for the last nine years, inVentiv Health Consulting has surveyed pharmaceutical and biotech dealmakers to assess their intentions for the next 12 …
